Also listed on Programmable Medicine, LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends no later than Dec 4, 2040 · Medium confidence
20-year base term ends Dec 4, 2040
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Dec 4, 2020
Dec 4, 2040
Oct 22, 2024
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 4, 2020, when application 17/112,255, the earliest non-provisional in its chain, was filed (this one was filed Jan 26, 2023) | Dec 4, 2040 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Dec 4, 2040 | Medium confidence |
This family
| US 11,612,660 | In force Dec 2040 | Dec 2040 |
| US 12,121,585 | this patent no later than Dec 2040 | no later than Dec 2040 |
| Application 18/825,168 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 10, 2024 Reel 67669, frame 250 | Cleland, Jeffrey; Sharma, Rishi; Appiani, Santiago | Ashvattha Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 30, 2024 Reel 69066, frame 586 | Ashvattha Therapeutics, Inc. | Sagent Group, LLC | Security Interest |
| May 29, 2025 Reel 71258, frame 198 | Sagent Group, LLC, as Agent | Ashvattha Therapeutics, Inc. | Release of Security Interest |
| Dec 9, 2025 Reel 73157, frame 501 | Ashvattha Therapeutics, Inc. | Programmable Medicine, LLC | Assignment of Assignor's Interest |
| Dec 9, 2025 Reel 73157, frame 575 | Programmable Medicine, LLC | Programmable Medicine Operating Company | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Dec 4, 2040. We will not guess the cap.